Cancer statistics, 2016

Cited by (1,069)

Items 701–800 of 1,069

1. Glucose Metabolism in the Progression of Prostate Cancer
   Francesca Cutruzzolà, Giorgio Giardina, Marina Marani, Alberto Macone, Alessandro Paiardini, Serena Rinaldo, Alessio Paone · 2017 · Frontiers in Physiology
2. Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
   Kae Nakamura, Peng Hui Yang, Fumi Utsumi, Hiromasa Tanaka, Masaaki Mizuno, Shinya Toyokuni, Masaru Hori, Fumitaka Kikkawa, Hiroaki Kajiyama · 2017 · Scientific Reports
3. Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine
   Tania Jaber, Steven Gerard Waguespack, Maria E. Cabanillas, Mohamed Elbanan, Thinh H. Vu, Ramona Dadu, Steven I. Sherman, Moran Amit, Elmer B Santos, Mark Zafereo et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
4. Tetrazoles as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies
   Neha Dhiman, Kamalpreet Kaur, Vikas Jaitak · 2020 · Bioorganic & Medicinal Chemistry
5. Recapitulating Pancreatic Tumor Microenvironment through Synergistic Use of Patient Organoids and Organ‐on‐a‐Chip Vasculature
   Lai, Benjamin Fook Lun, Lu, Rick Xing Ze, Hu, Yangshuo, Davenport Huyer, Locke, Dou, Wenkun, Wang, Erika Yan, Radulovich, Nikolina, Tsao, Ming Sound, Sun, Yu, Radisic, Milica · 2020 · Advanced Functional Materials
6. Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
   Yang, Hao, Zou, Xiaoming, Yang, Shifeng, Zhang, Ange, Li, Nana, Ma, Zhen · 2023 · Frontiers in Immunology
7. Alcohol, smoking and risk of oesophago-gastric cancer
   Jing Dong, Aaron P. Thrift · 2017 · Best Practice & Research Clinical Gastroenterology
8. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer
   Saeed Farajzadeh Valilou, Mahsa Keshavarz‐Fathi, Nicola Silvestris, Antonella Argentiero, Nima Rezaei · 2018 · Cytokine & Growth Factor Reviews
9. Intracellular and extracellular TGF-β signaling in cancer: some recent topics
   Kohei Miyazono, Yoko Katsuno, Daizo Koinuma, Shogo Ehata, Masato Morikawa · 2018 · Frontiers of Medicine
10. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4‐year follow‐up and analysis of relative progression‐free survival from the randomized ELOQUENT‐2 trial
    Meletios Athanasios Dimopoulos, Sagar Lonial, Keith A. Betts, Clara C. Chen, Miriam L. Zichlin, Alexander Brun, James Signorovitch, Dinara Makenbaeva, Sabeen Fatima Mekan, Oumar Sy et al. · 2018 · Cancer
11. Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
    Florian Janisch, Shahrokh François Shariat, Pascal Baltzer, Harun Fajković, Shoji Kimura, Takehiro Iwata, Philipp Korn, Lin Yang, Petr V. Glybochko, Michael Rink et al. · 2019 · World Journal of Urology
12. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
    Harras B. Zaid, William P. Parker, Nida S. Safdar, Boris Gershman, Patricia J. Erwin, Mohammad Hassan Murad, Stephen Anthony Boorjian, Brian Addis Costello, Robert Houston Thompson, Bradley C. Leibovich · 2016 · The Journal of Urology
13. Automatic segmentation of dermoscopy images using saliency combined with Otsu threshold
    Haidi Fan, Fengying Xie, Li Yang, Zhiguo Jiang, Jie Liu · 2017 · Computers in Biology and Medicine
14. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune
    Zhansheng Jiang, Yanfang Yang, Yinli Yang, Yu Zhang, Zhensong Yue, Zhanyu Pan, Xiubao Ren · 2017 · Biomedicine & Pharmacotherapy
15. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy
    Xiaoyan Zhang, Meng Zhang, Qing Cong, Mingxing Zhang, Mengyu Zhang, Yingying Lu, Congjian Xu · 2017 · The International Journal of Biochemistry & Cell Biology
16. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression
    Ru Wang, Zhihong Ma, Ling Feng, Yifan Yang, Tan Chen, Qian Shi, Meng Lian, Shizhi He, Hongzhi Ma, Jugao Fang · 2018 · Molecular Cancer
17. RETRACTED ARTICLE: m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5
    Yi Zhang, Min Kang, Bin Zhang, Fanchao Meng, Jun Ho Song, Hiroshi Kaneko, Fumio Shimamoto, Bo Tang · 2019 · Molecular Cancer · Retracted
18. Automatic prostate and prostate zones segmentation of magnetic resonance images using DenseNet-like U-net
    Nader Aldoj, Federico Biavati, Florian Michallek, Sebastian Stober, Marc Dewey · 2020 · Scientific Reports
19. Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics
    Li, Kai, Nejadnik, Hossein, Daldrup-Link, Heike E. · 2017 · Drug Discovery Today
20. RGD peptide-based non-viral gene delivery vectors targeting integrin α _v β ₃ for cancer therapy
    Fu, Shuang, Xu, Xiaodong, Ma, Yu, Zhang, Shubiao, Zhang, Shufen · 2019 · Journal of drug targeting
21. Children and adolescents coping with cancer: Self- and parent reports of coping and anxiety/depression.
    Bruce E. Compas, Léandra Desjardins, Kathryn A. Vannatta, Tammi Young‐Saleme, Erin M. Rodríguez, Madeleine J. Dunn, Heather Bemis, Sarah M. De Snyder, Cynthia A. Gerhardt · 2014 · Health Psychology
22. Modeling Human Cancers in Drosophila
    Masahiro Sonoshita, Ross Leigh Cagan · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
23. LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation
    C Zhou, Chuanshu Huang, Jia‐Bin Wang, Haishan Huang, Juncheng Li, Qipeng Xie, Yunzhi Liu, Junlan Zhu, Ying Li, D Zhang et al. · 2017 · Oncogene
24. Novel Approach of Using Near-Infrared Responsive PEGylated Gold Nanorod Coated Poly( l -lactide) Microneedles to Enhance the Antitumor Efficiency of Docetaxel-Loaded MPEG-PDLLA Micelles for Treating an A431 Tumor
    Ying Hao, Mingling Dong, TaoYe Zhang, Jinrong Peng, Yanpeng Jia, Yiping Cao, Zhiyong Qian · 2017 · ACS Applied Materials & Interfaces
25. Targeted drug delivery to melanoma
    Qi Liu, Manisit Das, Yun Liu, Leaf Huang · 2017 · Advanced Drug Delivery Reviews
26. Parabacteroides distasonis attenuates toll‐like receptor 4 signaling and Akt activation and blocks colon tumor formation in high‐fat diet‐fed azoxymethane‐treated mice
    Gar Yee Koh, Anne V Kane, Kyongbum Lee, Qiaobing Xu, Xian Wu, Jatin Roper, Joel B. Mason, Jimmy W. Crott · 2018 · International Journal of Cancer
27. Photothermal-Activatable Fe 3 O 4 Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy
    Rui Ge, Cangwei Liu, Xue Zhang, Wenjing Wang, Binxi Li, Jie Liu, Yi Liu, Hongchen Sun, Daqi Zhang, Yuchuan Hou et al. · 2018 · ACS Applied Materials & Interfaces
28. Nanoparticle Systems for Cancer Vaccine
    Ru M. Wen, Afoma C. Umeano, Yi Kou, Jian Xu, Ammad Ahmad Farooqı · 2019 · Nanomedicine
29. IL‐6 promotes metastasis of non‐small‐cell lung cancer by up‐regulating TIM‐4 via NF‐κB
    Wen Liu, Hongxing Wang, Fuxiang Bai, Lu Ding, Yanyan Huang, Changchang Lu, Siyuan Chen, Chunyang Li, Xuetian Yue, Xiaohong Liang et al. · 2020 · Cell Proliferation
30. NIR-responsive cancer cytomembrane-cloaked carrier-free nanosystems for highly efficient and self-targeted tumor drug delivery
    Zhang, Ning, Li, Minghui, Sun, Xuetan, Jia, Huizhen, Liu, Wenguang · 2018 · Biomaterials
31. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis
    Yongchen Guo, Yonghua Bao, Ming Ma, Wancai Yang · 2017 · International Journal of Molecular Sciences
32. Joint learning for pulmonary nodule segmentation, attributes and malignancy prediction
    Botong Wu, Zhen Zhou, Jianwei Wang, Yizhou Wang · 2018 · IEEE International Symposium on Biomedical Imaging (ISBI)
33. Epidemiology of venous thromboembolism in the Framingham Heart Study
    Marja Kaarina Puurunen, Philimon Nyakauru Gona, Martin G. Larson, Joanne M. Murabito, Jared W. Magnani, Christopher J. O’Donnell · 2016 · Thrombosis Research
34. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
    Marina Riggio, María Cecilia Perrone, María L. Polo, María Jimena Rodriguez, María May, Martı́n C. Abba, Claudia Lanari, Virginia Novaro · 2017 · Scientific Reports
35. Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update
    Leah L. Zullig, Kellie J. Sims, Rebecca B. McNeil, Christina Dawn Williams, George L. Jackson, Dawn Provenzale, Michael J. Kelley · 2017 · Military Medicine
36. The Use of Nanoparticulates to Treat Breast Cancer
    Xiaomeng Tang, Welley Siu Loc, Cheng Dong, Gail L. Matters, Peter J. Butler, MARK A. KESTER, Craig Meyers, Yixing Jiang, James H. Adair · 2017 · Nanomedicine
37. FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
    Gwynn Ison, Lynn Jackson Howie, Laleh Amiri‐Kordestani, Lijun Zhang, Shenghui W. Tang, Rajeshwari Sridhara, Vadryn Pierre, Rosane Charlab, Anuradha Ramamoorthy, Pengfei Song et al. · 2018 · Clinical Cancer Research
38. Ovarian cancer screening: Current status and future directions
    Zachary Nash, Usha Menon · 2020 · Best Practice & Research Clinical Obstetrics & Gynaecology
39. Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging
    Mohammed Saleh, Mayur Virarkar, Sanaz Javadi, Sherif B. Elsherif, Silvana de Castro Faria, Priya Bhosale · 2020 · American Journal of Roentgenology
40. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis
    Yongyan Wu, Yuliang Zhang, Xiwang Zheng, Fengsheng Dai, Yan Lu, Li Dai, Min Niu, Huina Guo, Wenqi Li, Xuting Xue et al. · 2020 · Molecular Cancer
41. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies
    Kishna Ram Senwar, Pankaj Sharma, T. Srinivasa Reddy, Manish Kumar Jeengar, Veena Nayak, V.G.M. Naidu, Ähmed Kamal, Nagula Shankaraiah · 2015 · European Journal of Medicinal Chemistry
42. Analysis of Trends in US Melanoma Incidence and Mortality
    Alex M. Glazer, Richard R. Winkelmann, Aaron S. Farberg, Darrell S. Rigel · 2016 · JAMA Dermatology
43. Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
    Sandro Pasquali, Alessandro Gronchi · 2017 · Therapeutic Advances in Medical Oncology
44. FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy
    Yangmin M. Ning, Daniel L. Suzman, Virginia Ellen Maher, Lijun Zhang, Shenghui W. Tang, Tiffany K. Ricks, Todd R. Palmby, Wentao Fu, Qi Liu, Kirsten B. Goldberg et al. · 2017 · The Oncologist
45. Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
    Ashish Vittalrao Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith, Sarah M. Jenkins, Robert L. Foote, Jan L. Kasperbauer, John C. Morris, Mabel M. Ryder, Samer Alsidawi, Crystal R. Hilger et al. · 2017 · The Journal of Clinical Endocrinology & Metabolism
46. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011
    Elizabeth Ann L. Enninga, Justin C. Moser, Amy L. Weaver, Svetomir N. Markovic, Jerry D. Brewer, Alexey A. Leontovich, Tina J. Hieken, Lynne T. Shuster, Lisa A. Kottschade, Ariadna Olariu et al. · 2017 · Cancer Medicine
47. The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer
    Shasha Tao, Montserrat Rojo de la Vega, Eli Chapman, Aikseng Ooi, Donna D. Zhang · 2017 · Molecular Carcinogenesis
48. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery
    Haihong Zha, Yuping A. Cai, Yandong Yin, Zhuozhong Wang, Kang Li, Zheng‐Jiang Zhu · 2018 · Analytical Chemistry
49. Emerging landscape of circular RNAs in lung cancer
    Wei Hu, Zhuoyue Bi, Zhenlong Chen, Cong Liu, Linlin Li, Feng Zhang, Qun Yong Zhou, Wei Zhu, Yangyiyan Song, Bo-Tao Zhan et al. · 2018 · Cancer Letters
50. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway
    Yu Liu, Tong Lin, Yan Luo, Xin Li, Gaowen Chen, Yifeng Wang · 2018 · Journal of Cellular Biochemistry
51. PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer
    Yang Wang, Tae Hyun Kim, Shamileh Fouladdel, Zhuo Zhang, Payal Soni, Angel Qin, Lili Zhao, Ebrahim Azizi, Theodore Steven Lawrence, Nithya Ramnath et al. · 2019 · Scientific Reports
52. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
    Anthony J.J. Dohan, B. Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe A. Soyer, Jaafar Bennouna, François Ghiringhelli, Emilie Barbier, Valérie Boige et al. · 2019 · Gut
53. GP-CNN-DTEL: Global-Part CNN Model With Data-Transformed Ensemble Learning for Skin Lesion Classification
    Peng Tang, Qiaokang Liang, Xintong Yan, Shao Xiang, Dan Zhang · 2020 · IEEE Journal of Biomedical and Health Informatics
54. Cancer Cell–Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti–PD-1 Therapy in Lung Adenocarcinoma
    Amber M. Johnson, Bonnie Bullock, Alexander J. Neuwelt, Joanna M. Poczobutt, Rachael E. Kaspar, Howard Y. Li, Jeff Kwak, Katharina Hopp, Mary C. M. Weiser-Evans, Lynn E. Heasley et al. · 2020 · The Journal of Immunology
55. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management
    Slominski, Andrzej T, Brożyna, Anna A, Zmijewski, Michal A, Jóźwicki, Wojciech, Jetten, Anton M, Mason, Rebecca S, Tuckey, Robert C, Elmets, Craig A · 2017 · Laboratory Investigation
56. Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform
    Lanz, Henriette L., Saleh, Anthony, Kramer, Bart, Cairns, Junmei, Ng, Chee Ping, Yu, Jia, Trietsch, Sebastiaan J., Hankemeier, Thomas, Joore, Jos, Vulto, Paul et al. · 2017 · BMC Cancer
57. Yacon (Smallanthus sonchifolius) as a Food Supplement: Health-Promoting Benefits of Fructooligosaccharides
    Brunno Felipe Ramos Caetano, Nelci Antunes de Moura, Ana Raquel Lopes Soares de Almeida, Marcos Correa Dias, Kátia Sivieri, Luı́s Fernando Barbisan · 2016 · Nutrients
58. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20)
    Kit Man Wong, Kathryn J. Horton, Andrew L. Coveler, Sunil R. Hingorani, William Proctor Harris · 2017 · Current Oncology Reports
59. BRCA mutation in ovarian cancer: testing, implications and treatment considerations
    Robert T. Neff, Leigha A. Senter, Ritu Salani · 2017 · Therapeutic Advances in Medical Oncology
60. Regulation of inflammation by members of the formyl-peptide receptor family
    Keqiang Chen, Zhiyao Bao, Wanghua Gong, Peng Tang, Teizo Yoshimura, Ji Ming Wang · 2017 · Journal of Autoimmunity
61. Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
    Andrew Gdowski, Amalendu Prakash Ranjan, Jamboor K. Vishwanatha · 2017 · Journal of Experimental & Clinical Cancer Research
62. Vitamin D exposure and Risk of Breast Cancer: a meta-analysis
    Nuria Estébanez, Inés Gómez‐Acebo, Camilo Palazuelos, Javier Llorca, Trinidad Dierssen‐Sotos · 2018 · Scientific Reports
63. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway
    Xue Jun Gao, Tao Qin, Jun Mao, Jun Zhang, Shujun Fan, Ying Lü, Zhigang Sun, Qingqing Zhang, Bo Song, Lianhong Li · 2019 · Journal of Experimental & Clinical Cancer Research
64. The Potential Effect of Metformin on Cancer: An Umbrella Review
    Hong Yu, Xi Zoë Zhong, Peng Gao, Jinxin Shi, Zhonghua Wu, Zhexu Guo, Zhenning Wang, Yongxi Song · 2019 · Frontiers in Endocrinology
65. Critical care of patients with cancer
    Alexander Shimabukuro‐Vornhagen, Boris Böll, Matthias Kochanek, E. Azoulay, Michael S. von Bergwelt‐Baildon · 2016 · CA A Cancer Journal for Clinicians
66. NCCN Guidelines Insights: Bladder Cancer, Version 2.2016
    Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Rick Bangs, Stephen Anthony Boorjian, Mark K. Buyyounouski, Jason Alexander Efstathiou, Thomas W. Flaig, Terence W. Friedlander, Richard Evan Greenberg et al. · 2016 · Journal of the National Comprehensive Cancer Network
67. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
    Lihui Wang, Xing Liu, Yong Ren, Jingyuan Zhang, Junli Chen, Wenlong Zhou, Wei Guo, Xiaoxuan Wang, Huiping Chen, Meng Li et al. · 2017 · Cell Death and Disease
68. Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
    Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuß, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges et al. · 2017 · PLoS ONE
69. Glycans as Biomarkers in Prostate Cancer
    Emma Scott, Jennifer Munkley · 2019 · International Journal of Molecular Sciences
70. A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer
    Alison Crawford, Lauric Haber, Marcus P. Kelly, Kristin Vazzana, Lauren Canova, Priyanka Ram, Arpita Pawashe, Jennifer Finney, Sumreen Jalal, Danica Chiu et al. · 2019 · Science Translational Medicine
71. Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer
    Ilem D. Rosero, Robinson Ramírez‐Vélez, Alejandro Lucía, Nicolás Martínez‐Velilla, Alejandro Santos‐Lozano, Pedro L. Valenzuela, Idoia Morilla, Míkel Izquierdo · 2019 · Cancers
72. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals
    Chuan Li, Jia Zhang, Yu-Jiao ZU, Shu-Fang NIE, Jun Cao, Qian WANG, Shaoping Nie, Zeyuan Deng, Mingyong Xie, Shu Fen Wang · 2015 · Chinese Journal of Natural Medicines
73. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway
    Hongying Liu, Gang Wang, Lili Yang, Jianjun Qu, Zhihui Yang, Xiangyu Zhou · 2016 · PLoS ONE
74. Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction
    Samer T. Tohme, Hamza O. Yazdani, Yao Liu, Patricia Loughran, Dirk J. van der Windt, Hai Huang, Richard L. Simmons, Sruti Shiva, Sheng Tai, Allan Tsung · 2017 · Hepatology
75. TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis
    Reem A. Malek, Rajendra P. Gajula, Russell D. Williams, Belinda Nghiem, Brian Wesley Simons, Katriana M. Nugent, Hailun Wang, Kekoa Taparra, Ghali Lemtiri-Chlieh, Arum R. Yoon et al. · 2017 · Cancer Research
76. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo
    Yan Fei Wen, Wei Zhang, Ningqiang Gong, Yifeng Wang, Hongbo Guo, Weisheng Guo, Paul C. Wang, Xing‐Jie Liang · 2017 · Nanoscale
77. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment
    Maria Plamenova Nikolova, Enamala Manoj Kumar, Murthy S. Chavali · 2022 · Pharmaceutics
78. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
    Xiaoqing He, Liying Wang, Heimo Riedel, Kai Wang, Yong Suk Yang, Cerasela Zoica Dinu, Yon Rojanasakul · 2017 · Molecular Cancer
79. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients
    Yu Yu, Lei Qian, Jiuwei Cui · 2017 · Molecular and Clinical Oncology
80. The Relevance of Assessing the Cell Proliferation Factor Ki-67 in Squamous Cell Carcinoma of the Larynx
    Jelena Vukelić, Renata Dobrila-Dintinjana, Andrea Dekanić, Blažen Marijić, Aleksandar Čubranić, Tamara Braut · 2019 · BioMed Research International
81. GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies
    Weixing Dai, Ye Xu, Shaobo Mo, Qingguo Li, Jun Yu, Renjie Wang, Yanlei Ma, Yan Ni, Wenqiang Xiang, Lingyu Han et al. · 2020 · Signal Transduction and Targeted Therapy
82. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection
    Francesca V. Mertan, Matthew D. Greer, Joanna H. Shih, Arvin Koruthu George, Michael Kongnyuy, Akhil Muthigi, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke et al. · 2016 · The Journal of Urology
83. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
    Leilei Tao, Guichun Huang, Rui Wang, Yan Pan, Zhenyue He, Xiaoyuan Chu, Haizhu Song, Longbang Chen · 2016 · Scientific Reports
84. Computer-aided diagnosis of lung nodule using gradient tree boosting and Bayesian optimization
    Mizuho Nishio, Mitsuo Nishizawa, Osamu Sugiyama, Ryosuke Kojima, Masahiro Yakami, Tomohiro Kuroda, Kaori Togashi · 2018 · PLoS ONE
85. A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
    Mehran Makvandi, Austin R. Pantel, Lauren Ende Schwartz, Erin K. Schubert, Kuiying Xu, Chia‐Ju Hsieh, Catherine Hou, Hyoung Kim, Chi-Chang Weng, Harrison David Winters et al. · 2018 · Journal of Clinical Investigation
86. VHL and Hypoxia Signaling: Beyond HIF in Cancer
    Jing Zhang, Qing Hua Zhang · 2018 · Biomedicines
87. Pancreatic adenocarcinomas with mature blood vessels have better overall survival
    Eriko Katsuta, Qianya Qi, Xuan Peng, Steven N. Hochwald, Li Yan, Kazuaki Takabe · 2019 · Scientific Reports
88. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells
    Hu, Chun-Mei, Tien, Sui-Chih, Hsieh, Ping-Kun, Jeng, Yung-Ming, Chang, Ming-Chu, Chang, Yu-Ting, Chen, Yi-Ju, Chen, Yu-Ju, Lee, Eva Y.-H.P., Lee, Wen-Hwa · 2019 · Cell Metabolism
89. Gastric cancer – clinical and epidemiological aspects
    Marino Venerito, Alexander Link, Theodoros Rokkas, Peter Malfertheiner · 2016 · Helicobacter
90. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy
    Jiao Wang, Yue Wang, Qiang Liu, Linnan Yang, Rongrong Zhu, Chengzhong Yu, Shilong Wang · 2016 · ACS Applied Materials & Interfaces
91. Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer
    Janna Manjelievskaia, Derek W. Brown, Katherine A. McGlynn, William F. Anderson, Craig D. Shriver, Kangmin Zhu · 2017 · JAMA Surgery
92. Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents
    Jianqiang Zhu, Ming Xu, Ming Gao, Zhihong Zhang, Yong Xu, Tian Xia, Sijin Liu · 2017 · ACS Nano
93. Molecular subtypes in cancers of the gastrointestinal tract
    Maarten F. Bijlsma, Anguraj Sadanandam, Patrick B. O. Tan, Louis Vermeulen · 2017 · Nature Reviews Gastroenterology & Hepatology
94. The role of biomarkers in the management of epithelial ovarian cancer
    Wei‐Lei Yang, Zhen Lü, Robert C. Bast · 2017 · Expert Review of Molecular Diagnostics
95. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
    Mahaveer Singh, Hemant R. Jadhav · 2017 · Drug Discovery Today
96. The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
    Lu Gan, Midie Xu, Rui‐Xi Hua, Cong Tan, Jieyun Zhang, Yiwei Gong, Zhenhua Wu, Weiwei Weng, Weiqi Sheng, Weijian Guo · 2018 · Journal of Hematology & Oncology
97. Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
    Yiqiao Huang, Xianhan Jiang, Xue Liang, Ganggang Jiang · 2018 · Oncology Letters
98. Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy
    Han Wang, Bin Lv, Zhongmin Tang, Meng Zhang, Weiqiang Ge, Yanyan Liu, Xinhong He, Kuaile Zhao, Xiangpeng Zheng, Mingyuan He et al. · 2018 · Nano Letters
99. Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma
    Aiping Luo, Xuantong Zhou, Xing Shi, Yahui Zhao, Yu Men, Xiao Chang, Hongyan Chen, Fang Ding, Yi Li, Dan Su et al. · 2019 · Oncogene
100. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review
     Gabriel Francisco Pereira Aleixo, Grant Richard Williams, Kirsten A. Nyrop, Hyman Bernard Muss, Shlomit Strulov Shachar · 2019 · Breast Cancer Research and Treatment